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Abstract
The study of transcription using genomic tiling arrays has lead to the identification of numerous
additional exons. One example is the MECP2 gene on the X chromosome; using 5’RACE and RT-
PCR in human tissues and cell lines, we have found more than 70 novel exons (RACEfrags)
connecting to at least one annotated exon.. We sequenced all MECP2-connected exons and
flanking sequences in 3 groups: 46 patients with the Rett syndrome and without mutations in the
currently annotated exons of the MECP2 and CDKL5 genes; 32 patients with the Rett syndrome
and identified mutations in the MECP2 gene; 100 control individuals from the same geoethnic
group. Approximately 13kb were sequenced per sample, (2.4Mb of DNA resequencing). A total of
75 individuals had novel rare variants (mostly private variants) but no statistically significant
difference was found among the 3 groups. These results suggest that variants in the newly
discovered exons may not contribute to Rett syndrome. Interestingly however, there are about
twice more variants in the novel exons than in the flanking sequences (44 vs. 21 for approximately
1.3 Mb sequenced for each class of sequences, p = 0.0025). Thus the evolutionary forces that
shape these novel exons may be different than those of neighboring sequences.
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INTRODUCTION
The elucidation of the genome function is one of the most important challenges in
biomedical research. The ENCODE pilot project (Birney, et al., 2007) provided initial data
for the functional analysis of a selected 1% of the human genome. Surprisingly, the
ENCODE study has revealed the existence of many additional exons connected to the
currently annotated genes (Denoeud, et al., 2007). 5’ RACE (Rapid Amplification of cDNA
Ends) experiments in many different tissues, followed by hybridization on tiling repeat-
masked arrays, have shown numerous “exons” (referred to as RACEfrags), not previously
described, of unknown function, extending further beyond the known 5’ boundaries of
genes. Subsequent RT-PCR and sequencing experiments of the amplicons have verified the
RACEfrags (Djebali, et al., 2008).
RACEfrags have been reported to be expressed at a similar level to the annotated coding
exons, and many are found in a single tissue or cell line (Denoeud, et al., 2007). Remarkably
they are not very well conserved throughout mammalian evolution (Birney, et al., 2007;
Denoeud, et al., 2007; Margulies, et al., 2007). The biological importance of these new
“exons” is unclear. In order to provide functional evidence we sought to search for
pathogenic mutations in RACEfrags of genes that are associated with known genetic
disorders.
We selected the MECP2 (MIM# 300005) gene on the Xq chromosome as the case study.
MECP2 has two isoforms (Kriaucionis and Bird, 2004; Mnatzakanian, et al., 2004) and
pathogenic mutations are responsible for Rett syndrome (MIM# 312750) (Amir, et al., 1999;
Wan, et al., 1999), a frequent monogenic disorder with severe mental retardation in girls
(Bienvenu, et al., 2006). The patients are typically born normal but their development is
abruptly stopped before the second year of life, resulting in a loss of the acquired abilities
and characteristic physical and behavioral findings (Percy and Lane, 2004; Segawa and
Nomura, 2005; Weaving, et al., 2005). In the classic cases of Rett syndrome, mutations in
the MECP2 gene are found in 90–95% of patients; however in the atypical forms
(Congenital, Forme Fruste: milder form, PSV: Preserved Speech Variant, Rett-like: patients
not fulfilling the diagnostic criteria but with clinical similarities, and early seizures) this rate
drops to less than 45% (Mari, et al., 2005; Scala, et al., 2005; Weaving, et al., 2005). Since a
considerable number of novel RACEfrags have been linked with the annotated exons of the
MECP2 gene, we hypothesized that variants within the newly described MECP2 RACEfrags
may be causally related to cases of Rett syndrome without known mutation in the MECP2,
CDKL5 (MIM# 300203) or FOXG1 (MIM# 164874) genes (the latter genes have been
associated with a minority of Rett syndrome cases (Mencarelli, et al., 2009; Tao, et al.,
2004; Weaving, et al., 2004)). Patients’ samples were provided from the Italian Rett Bank
(Sampieri, et al., 2007).
Our results show that RACEfrag variants are found in similar numbers in the samples from
Rett syndrome patients and the matched controls suggesting that nucleotide variants in the
newly discovered exons studied do not contribute to the pathogenesis of Rett syndrome.
Interestingly however, the variants in the novel exons are twice as frequent as those found in
flanking sequences. The significance of this result remains to be elucidated, implying
nonetheless that the evolutionary forces that shape these novel exons may be different than
those of neighboring sequences.
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MATERIALS AND METHODS
Samples
DNA samples from a total of 46 female patients with the clinical diagnosis of Rett syndrome
or one of its variants with no known mutations in the MECP2 (RefSeq NM_004992.3),
CDLK5 or FOXG1 genes, (referred to as group “PNM”) were collected. In addition,
samples from 32 female Rett syndrome patients with known mutations in the MECP2 gene
were studied (referred to as group “PM”). The patients of groups “PNM” and ”PM” were
provided by the Italian Rett Bank (Sampieri, et al., 2007) and the frequencies of the clinical
categories of the Rett syndrome for each group can be found in Figures 1A and 1B. For 28
of the patients from group “PM” detailed clinical scoring exists based on 10 or 24 clinical
parameters (Supp. Table S1). As expected there is a statistical difference in the phenotypic
scoring of patients with classic Rett and those with the PSV variant, (p= 0.0018 for 10
phenotypic variables or p= 0.0008 for 24 phenotypic variables). There was no difference
between the patients with classic Rett and those with FF or Rett-like variants (likely because
of the small sample size).
The control group, (referred to as “CNT”), consisted of 100 unrelated, randomly selected
females from the Gaslini Children’s Hospital blood bank in Genova, Italy. The control
subjects were Italian with ancestors from all parts of the country, and none had a first-degree
relative with Rett syndrome. The samples from all control subjects were anonymous.
Identification of RACEfrags
The coordinates of the RACEfrags connected with the MECP2 gene that are studied here
were taken from our recently published studies (Denoeud, et al., 2007; Djebali, et al., 2008).
Briefly, using an oligonucleotide primer on the 3rd exon of MECP2, 5’RACE reactions were
performed in cDNA samples and subsequently the products were hybridized against repeat-
masked tiling arrays of the ENCODE (Birney, et al., 2007) regions consisting of 25-mers
with 4bp overlap. Data from 13 tissues (brain, placenta, colon, small intestine, heart, spleen,
kidney, stomach, lung, testis, muscle, liver, fetal and adult brain) were used (Denoeud, et al.,
2007; Djebali, et al., 2008).
Verification of RACEfrags and connectivity
Ten MECP2-related RACEfrags out of the 71 identified were randomly selected for
validation and identification of the exact splice sites. cDNA from the original samples used
for identification of the RACEfrags (Denoeud, et al., 2007) were amplified by using the
primer of the index exon as forward and a primer on the RACEfrag as reverse. The reverse
primers were chosen not to span possible splice junctions. Amplification was done using
JumpStart (Sigma) and subsequently the fragments were cloned using the TopoTA kit
(Invitrogen), Three clones were picked per plate and sequenced (ABI 3130XL). All the RT-
PCRs resulted in at least one identifiable amplicon by sequencing.
In order to estimate the abundance of the RACEfrags in relation to the annotated exons
Real-Time PCR (RTPCR) assays were performed using 8ng of fetal brain polyA+ RNA
(Ambion) per reaction using one-step qRTPCR kit (ABI). Given variations in primer
efficiencies, two primer pairs were selected per variant: one primer pair exactly overlapping
the variant, and another within 200 bp of the variant; additionally 3 primer pairs to 3
different exons of MeCP2 were also selected for comparison (Supp. Table S2). A total of 8
RACEfrag were tested.
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Detection of nucleotide variants
All RACEfrags studied were sequenced in all 178 individuals by Sanger sequencing.
Amplification was done using JumpStart (Sigma). In all cases touchdown PCR programs
were used. The total number of PCR cycles was forty, during the first ten the annealing
temperature was gradually lowered from 65 to 55°C. A final round of amplification lasting 5
minutes was added at the end of the program. The sequence fragments included the
RACEfrag with at least 50bp upstream and downstream and when two adjacent RACEfrags
were separated with a maximum distance of 500bp all the intermediate fragment was
sequenced as well. Twenty-one PCR amplicons were amplified per sample (Figure 2).
Primers were designed using mostly Primer3 and are shown in Supp. Table S3.
The total amount of readable sequence for each DNA sample was 13118 bp, of which 7187
nucleotides (54.8%) were from RACEfrags and 5931 nucleotides (45.2%) from the flanking
areas. Variant identification was performed by manually reading the sequences using the
Staden Package. In order to define whether an identified variant should be considered inside
or outside a RACEfrag the hybridization data were used along with the RT-PCR data when
these were available. (Figure 3)
Statistical analysis
Fisher exact and Mann-Whitney-Wilcoxon tests were performed using the free statistical
software R. For the detection of difference in the number of variants within and outside of
RACEfrags, empirical p-value was calculated by performing 30.000 permutations. More
specifically the position of the variants was randomly permuted along the whole sequenced
area.
We used the Variscan Software (Hutter, et al., 2006; Vilella, et al., 2005) to perform a
population genetics analysis to calculate the nucleotide diversity (π or “pi”), the level of
nucleotide polymorphism (θ or “theta”) and the Tajima’s D value. For this analysis we
concatenated the sequenced DNA fragments to generate 3 sequence sets (i) All sequenced
regions (ii) Only regions corresponding to RACEfrags, (iii) Only regions flanking
RACEfrags.
RESULTS
A total of 13118 bp of DNA per sample (21 amplicons, 48.1% GC content, total amount of
sequence 2.33Mb) were sequenced. Of these, 7187 bp (54,8%) corresponded to the
RACEfrags as determined after the RT-PCRs (48.9% GC content). All the novel RACEfrags
linked to the annotated MECP2 gene irrespective of the tissue of origin or the detection
method are shown in Figure 2. The remaining 5931 bp (45.2%) per sample correspond to
areas flanking the RACEfrags.
RT-PCR experiments to verify the connectivity of the RACEfrags showed that in 15 out of
26 cases canonical splice sites (GT/AG) were used. For the remaining splicing events, the
donor site was non canonical in 10 cases (sequences identified: TA, GG, CC, CT), and the
acceptor was non canonical in 3 cases (sequences identified: GA, CC) (Djebali, et al., 2008).
We examined all 6 reading frames for a possible ORF but we noted that the RACEfrags
(with the exception of one exonified Alu sequence) do not show evidence for protein-coding
capacity (data not shown).
The median abundance of these RNAs was 2.7 fold lower then that of the MeCP2 annotated
exons, based on the difference in the median Ct of the MeCP2 exons vs median Ct of all 16
primer pairs in the SYBRgreen based assay (Supp. Table S4).
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Analysis of the re-sequencing data allowed the detection of a total of 65 novel sequence
variants were identified; Table 1 lists all the sequence variants and includes their genomic
position (hg17), the nucleotide change, the number of occurrences, the group in which they
were found (patients, controls), and whether they were found within or outside the
RACEfrags. All, but one (deletion of 1bp) were nucleotide substitutions; of these changes 50
(78%) were transitions, and 14 were transversions. For the first 5 variants identified in
patients without known MECP2/CDKL5 mutations, samples from the parents were
sequenced as well. In all cases the variants were either paternally or maternally inherited.
In order to assess whether variants within MECP2 RACEfrags could be involved in Rett
syndrome we compared the frequency of variants in the RACEfrags among the 3 groups of
the study. Table 2 provides the number of samples with variants (total or within and outside
the RACEfrags) per group along with the respective p-values calculated after comparing the
two groups of patients (“PNM” and “PM”) with the control group “CNT”. No p-value
reached statistical significance. In addition, no statistical difference was noted when
comparing the number of variants in patients with classic Rett versus the other phenotypic
groups. Thus, no evidence was found for pathogenic mutations causing Rett syndrome in the
MECP2 RACEfrags.
Interestingly, however, we observed a difference in the total number of variants in and
outside the RACEfrags (Figure 3 shows the definition used in this study concerning the
position of a SNP inside or outside a RACEfrag): 44 variants were found inside the
RACEfrags, and only 21 were detected outside. The resulting empirical p-value after 30.000
permutations is 0.025 showing that there is a statistically significant difference in the
frequency of variants inside versus outside the RACEfrags.
The observation that RACEfrags contained twice as many rare variants than the
neighbouring sequences is remarkable. The θ value of all the target DNA segments studied
is 8.86 × 10−4; however the θ value for RACEfrags was 10.56 × 10−4 while that of the
flanking regions was only 6.79 ×10−4.
The mean π value of our data set is 1.64 × 10−4; this value is 4 times lower than the average
value of 6.82 × 10−4 reported from the study of 322 genes resequenced in 23 CEPH
individuals (22Kb per sample, 7108kb total) (Bhangale, et al., 2005) (http://
pga.gs.washington.edu/summary_stats.html) although significant variation is noted with the
values of that study ranging from 0.21 to 27.16 × 10−4.
By performing an analysis on the whole concatenated sequenced area, we find a value of
Tajima’s D statistic, which measures deviations form neutrality of population sationarity
equal to −2.38. The values of Tajima’s D computed separately on the concatenated
RACEfrag and on non RACEfrag areas, the values are −2.51 and −1.78 respectively
showing that the RACEfrags are the main contributors to the large negative value observed
in that region.
DISCUSSION
The recent discovery that a substantial part of our genome is likely to be transcribed is
challenging established views on the functional fraction of the genome (Cheng, et al., 2005).
The availability of genomic tiling arrays provide novel transcription maps that include not
only the already annotated genic regions, but also a substantial number of additional regions
either inter- or intragenic. RACE and RT-PCR reactions utilizing RNAs from a large
number of tissues and cell lines provide a connectivity of the novel transcribed sites with the
annotated transcripts (Djebali, et al., 2008). The function of this rich transcription network is
unknown and currently under investigation in numerous laboratories.
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The function of a genomic element is often identified or inferred by studying the phenotypic
consequences of either natural or induced pathogenic mutations (Antonarakis and
Beckmann, 2006). We thus hypothesized that if RACEfrags were functionally linked to the
annotated connected gene, then mutations in these RACEfrags may cause the same
phenotype as their connected gene. Following our work on novel RACEfrags in the pilot
ENCODE regions of the human genome (Birney, et al., 2007) we selected the MECP2 gene
on Enm006 on the X chromosome as a test case. The annotated version of the MECP2 gene
has been linked to several additional RACEfrags, and pathogenic mutations in the annotated
exons cause Rett syndrome (MIM# 312750), an X-linked dominant disease (Amir, et al.,
1999; Wan, et al., 1999). Since not all patients with the clinical diagnosis of Rett syndrome
have pathogenic MECP2 mutations, we reasoned that pathogenic or predisposing mutations
could be found in the DNAs of such Rett syndrome patients.
The results of this study suggest that rare variants in the MECP2-linked RACEfrags may not
contribute to the Rett syndrome. However, since it is unknown which of the RACEfrags are
likely to be important in the expression of the gene in the brain, and which of the variants
detected are likely to affect the function of the transcript, a potential effect could be missed
if all identified variants are considered.
We observed that RACEfrags harbor approximately twice as many variants than the
flanking areas (44 vs 21; p= 0.025) for roughly the same amount of sequence data. The θ
value of the whole DNA region sequenced was 8.86 ×10−4, but RACEfrags alone had θ =
10.56 ×10−4 versus 6.79 ×10−4 in the flanking regions. Data from literature are shown in
Table 3 and indicate that θ varies from 3.6 and 4×10−4 in the coding regions to 5–8×10−4 in
the introns. This suggests that the theta of RACEfrags found in this study is an outlier while
the flanking intronic regions have a θ value similar to that found in other studies.
Furthermore the θ value of the RACEfrags is similar to that calculated in an intergenic
region in chromosome 8q24 (10.2×10−4) (Yeager, et al., 2008), a gene desert linked to
various types of cancer (Haiman, et al., 2007; Kiemeney, et al., 2008; Zanke, et al., 2007).
The accumulation of variants in this region could signal the presence of a functional element
that evolves rapidly.
Tajima’s D value measuring deviation from neutral evolution has a value of −2.58 in the
RACEfrag regions and of −1.78 outside the RACEfrags. These negative values are
compatible with either positive selection or population expansion (Carlson, et al., 2005). The
distinction between the two alternatives is difficult given the fact that the human population
has expanded rapidly during the last millennia. It is apparent however that the RACEfrags
and their flanking regions are under different evolutionary constraints.
This study has failed to show that nucleotide variation within the RACEfrags is responsible
for the Rett syndrome or its phenotypic variants. This does not however mean that the
RACEfrags examined are non-functional. Functional analyses in cell culture systems or
whole animals may contribute to the functional annotation of each MECP2-linked
RACEfrag. The difficulty, however, in using experimental animals is that the majority of
RACEfrags are not well conserved among different species (Denoeud, et al., 2007). Thus the
study of natural pathogenic mutations is often the main way to verify functional genomic
regions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Makrythanasis et al. Page 6
Hum Mutat. Author manuscript; available in PMC 2013 July 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Acknowledgments
This study was supported by the ENCODE project grant from the NIH, the Italian Telethon grant (GTB07001C) to
ARen, and the MHV fellowship to LB.
REFERENCES
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by
mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999; 23(2):
185–188. [PubMed: 10508514]
Antonarakis SE, Beckmann JS. Mendelian disorders deserve more attention. Nat Rev Genet. 2006;
7(4):277–282. [PubMed: 16534515]
Bhangale TR, Rieder MJ, Livingston RJ, Nickerson DA. Comprehensive identification and
characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes. Hum
Mol Genet. 2005; 14(1):59–69. [PubMed: 15525656]
Bienvenu T, Philippe C, De Roux N, Raynaud M, Bonnefond JP, Pasquier L, Lesca G, Mancini J,
Jonveaux P, Moncla A, et al. The incidence of Rett syndrome in France. Pediatr Neurol. 2006;
34(5):372–375. [PubMed: 16647997]
Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder
M, Dermitzakis ET, Thurman RE, et al. Identification and analysis of functional elements in 1% of
the human genome by the ENCODE pilot project. Nature. 2007; 447(7146):799–816. [PubMed:
17571346]
Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP,
Kalyanaraman N, et al. Characterization of single-nucleotide polymorphisms in coding regions of
human genes. Nat Genet. 1999; 22(3):231–238. [PubMed: 10391209]
Carlson CS, Thomas DJ, Eberle MA, Swanson JE, Livingston RJ, Rieder MJ, Nickerson DA. Genomic
regions exhibiting positive selection identified from dense genotype data. Genome Res. 2005;
15(11):1553–1565. [PubMed: 16251465]
Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, Long J, Stern D, Tammana H, Helt G,
et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005;
308(5725):1149–1154. [PubMed: 15790807]
Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J, Lagarde J, Alioto T, Manzano C,
Chrast J, et al. Prominent use of distal 5' transcription start sites and discovery of a large number of
additional exons in ENCODE regions. Genome Res. 2007; 17(6):746–759. [PubMed: 17567994]
Djebali S, Kapranov P, Foissac S, Lagarde J, Reymond A, Ucla C, Wyss C, Drenkow J, Dumais E,
Murray RR, et al. Efficient targeted transcript discovery via array-based normalization of RACE
libraries. Nat Methods. 2008
Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon
A, Schirmer C, McDonald GJ, et al. Multiple regions within 8q24 independently affect risk for
prostate cancer. Nat Genet. 2007; 39(5):638–644. [PubMed: 17401364]
Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A.
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis.
Nat Genet. 1999; 22(3):239–247. [PubMed: 10391210]
Hutter S, Vilella AJ, Rozas J. Genome-wide DNA polymorphism analyses using VariScan. BMC
Bioinformatics. 2006; 7:409. [PubMed: 16968531]
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human
genome browser at UCSC. Genome Res. 2002; 12(6):996–1006. [PubMed: 12045153]
Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN, Gudmundsson J, Jakobsdottir
M, Bergthorsson JT, Sigurdsson A, et al. Sequence variant on 8q24 confers susceptibility to
urinary bladder cancer. Nat Genet. 2008
Kriaucionis S, Bird A. The major form of MeCP2 has a novel N-terminus generated by alternative
splicing. Nucleic Acids Res. 2004; 32(5):1818–1823. [PubMed: 15034150]
Makrythanasis et al. Page 7
Hum Mutat. Author manuscript; available in PMC 2013 July 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP, Axelrod N, Huang J, Kirkness EF,
Denisov G, et al. The diploid genome sequence of an individual human. PLoS Biol. 2007;
5(10):e254. [PubMed: 17803354]
Livingston RJ, von Niederhausern A, Jegga AG, Crawford DC, Carlson CS, Rieder MJ, Gowrisankar
S, Aronow BJ, Weiss RB, Nickerson DA. Pattern of sequence variation across 213 environmental
response genes. Genome Res. 2004; 14(10A):1821–1831. [PubMed: 15364900]
Margulies EH, Cooper GM, Asimenos G, Thomas DJ, Dewey CN, Siepel A, Birney E, Keefe D,
Schwartz AS, Hou M, et al. Analyses of deep mammalian sequence alignments and constraint
predictions for 1% of the human genome. Genome Res. 2007; 17(6):760–774. [PubMed:
17567995]
Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, Scala E, Longo I, Grosso S,
Pescucci C, et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible
for the early-onset seizure variant of Rett syndrome. Hum Mol Genet. 2005; 14(14):1935–1946.
[PubMed: 15917271]
Mencarelli MA, Kleefstra T, Katzaki E, Papa FT, Cohen M, Pfundt R, Ariani F, Meloni I, Mari F,
Renieri A. 14q12 Microdeletion syndrome and congenital variant of Rett syndrome. Eur J Med
Genet. 2009
Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ, Jones JR, Scherer SW,
Schanen NC, Friez MJ, et al. A previously unidentified MECP2 open reading frame defines a new
protein isoform relevant to Rett syndrome. Nat Genet. 2004; 36(4):339–341. [PubMed: 15034579]
Percy AK, Lane JB. Rett syndrome: clinical and molecular update. Curr Opin Pediatr. 2004; 16(6):
670–677. [PubMed: 15548931]
Renieri A, Mari F, Mencarelli MA, Scala E, Ariani F, Longo I, Meloni I, Cevenini G, Pini G, Hayek
G, et al. Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech
variant). Brain Dev. 2009; 31(3):208–216. [PubMed: 18562141]
Sampieri K, Meloni I, Scala E, Ariani F, Caselli R, Pescucci C, Longo I, Artuso R, Bruttini M,
Mencarelli MA, et al. Italian Rett database and biobank. Hum Mutat. 2007; 28(4):329–335.
[PubMed: 17186495]
Scala E, Ariani F, Mari F, Caselli R, Pescucci C, Longo I, Meloni I, Giachino D, Bruttini M, Hayek G,
et al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet.
2005; 42(2):103–107. [PubMed: 15689447]
Segawa M, Nomura Y. Rett syndrome. Curr Opin Neurol. 2005; 18(2):97–104. [PubMed: 15791137]
Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M, Sperner J, Fryns JP,
Schwinger E, Gecz J, et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/
STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet. 2004;
75(6):1149–1154. [PubMed: 15499549]
Vilella AJ, Blanco-Garcia A, Hutter S, Rozas J. VariScan: Analysis of evolutionary patterns from
large-scale DNA sequence polymorphism data. Bioinformatics. 2005; 21(11):2791–2793.
[PubMed: 15814564]
Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL,
Lo IF, et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at
CpG hotspots. Am J Hum Genet. 1999; 65(6):1520–1529. [PubMed: 10577905]
Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, Archer H, Evans J, Clarke
A, Pelka GJ, Tam PP, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder
with infantile spasms and mental retardation. Am J Hum Genet. 2004; 75(6):1079–1093.
[PubMed: 15492925]
Weaving LS, Ellaway CJ, Gecz J, Christodoulou J. Rett syndrome: clinical review and genetic update.
J Med Genet. 2005; 42(1):1–7. [PubMed: 15635068]
Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A, He W, Chen YJ, Makhijani V,
Roth GT, et al. The complete genome of an individual by massively parallel DNA sequencing.
Nature. 2008; 452(7189):872–876. [PubMed: 18421352]
Yeager M, Xiao N, Hayes RB, Bouffard P, Desany B, Burdett L, Orr N, Matthews C, Qi L, Crenshaw
A, et al. Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24
Makrythanasis et al. Page 8
Hum Mutat. Author manuscript; available in PMC 2013 July 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
associated with prostate and colon cancers. Hum Genet. 2008; 124(2):161–170. [PubMed:
18704501]
Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang
S, Chiang T, Crowdy E, et al. Genome-wide association scan identifies a colorectal cancer
susceptibility locus on chromosome 8q24. Nat Genet. 2007; 39(8):989–994. [PubMed: 17618283]
Makrythanasis et al. Page 9
Hum Mutat. Author manuscript; available in PMC 2013 July 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
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Figure 2.
Custom image from the UCSC genome browser (http://genome.ucsc.edu) (Kent, et al.,
2002) showing from top to bottom: (i) coordinates of the X chromosome, NCBI Build 35 (ii)
the exact positions of the primers used in the qRT-PCR to estimate the abundance of the
RACEfrags, (iii) the identified MECP2 RACEfrags, (iv) the PCR fragments used for
sequencing (primers are found in Supp. Table S2), (v) the known SNPs that were identified,
(vi) the novel variants identified during this study (vii) the RT-PCRs. The annotated exons
of MECP2, known mRNAs, and EST tracks are shown. Complementary information can be
found in Fig 2 in Djebali et al, 2008(Djebali, et al., 2008)
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Figure 3.
Localization of the different variants within and outside of RACEfrags. The distinction is
made after RACE and RT-PCR experiments as described in the text.
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Table 1
Catalogue of the variants discovered during the sequencing of the RACEfrags and the adjacent regions.
Variant Group no of
individuals
inside in original
Rxfrags
inside after after
RT-PCR
g.152819070 T>C CNT 1 þ þ
g.152819225 G>A PNM 1 þ þ
g.152819301 T>C CNT 1 þ þ
g.152819367 A>G PNM 1 þ
g.152819418 T>A CNT 1 þ
g.152819538delA CNT 1 þ
g.152819716 C>T CNT 1 þ
g.152819769 T>C CNT 1 þ
g.152819814 G>A CNT 1 þ
g.152819824 G>A CNT 1 þ þ
g.152819969 G>A PNM 2 þ þ
g.152819995 G>A CNT 1 þ þ
g.152820283 G>A CNT 2 þ þ
g.152820398 C>A PM 1 þ þ
g.152820464 C>T PM 1 þ þ
g.152820880 G>A PM, CNT 3 þ þ
g.152820972 G>T PNM 1
g.152822513 C>G CNT 1
g.152826382 C>T PNM 1 þ þ
g.152827405 T>G PNM, PM, CNT 4 þ þ
g.152827438 C>T CNT 1 þ þ
g.152827764 G>T CNT 1 þ þ
g.152828230 C>T PM 1
g.152828397 G>A PM 1
g.152834889 C>T CNT 1 þ
g.152834899 C>T CNT 1 þ þ
g.152834952 C>A CNT 1 þ þ
g.152835019 C>T PNM, PM, CNT 7 þ
g.152835204 T>C CNT 1 þ
g.152835546 T>C PNM 1 þ
g.152835857 C>T PNM 1
g.152843112 A>G CNT 1
g.152843604 C>T PNM 1 þ þ
g.152843622 T>C CNT 1 þ þ
g.152843625 T>C CNT 1 þ þ
g.152843695 A>C PNM 1 þ þ
Hum Mutat. Author manuscript; available in PMC 2013 July 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Makrythanasis et al. Page 14
Variant Group no of
individuals
inside in original
Rxfrags
inside after after
RT-PCR
g.152843701 T>C PNM 1 þ þ
g.152843955 T>A CNT 1
g.152844044 G>A CNT 1 þ
g.152844597 C>T CNT 1 þ þ
g.152844796 G>A CNT 1 þ þ
g.152845376 A>G PM 1 þ þ
g.152845794 T>C PM 1 þ þ
g.152845924 A>G CNT 1
g.152845948 G>A CNT 1
g.152846038 G>A PNM, PM, CNT 3 þ þ
g.152846239 T>C CNT 1 þ þ
g.152846244 G>A CNT 1 þ þ
g.152846387 C>T CNT 1
g.152846510 A>G CNT 1 þ
g.152846581 T>A CNT 1 þ
g.152845879 C>T PNM 1 þ þ
g.152868815 T>A PNM 1
g.152868846 C>T CNT 1
g.152868980 A>G PM 1
g.152874498 T>C CNT 1
g.152874573 T>G CNT 2
g.152877868 A>T CNT 2
g.152878128 G>A CNT 1 þ þ
g.152878962 C>T PNM, PM, CNT 11
g.152880633 C>G PNM 2
g.152880915 G>C PM 1
g.152883115 C>A CNT 1
g.152883356 G>A PNM 1
g.152819564 A>G CNT 1 þ
In the group column “PNM” stands for the patients where no mutation is found, “PM” for the group of patients where mutations have been found
and “CNT” for the healthy individuals control group.
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Table 3
The theta values (population mutation parameter or level of nucleotide polymorphism) calculated from
different studies are shown.
Genomic area Theta value (10−4) Reference
CDS, Venter genome 3.6 (Levy, et al., 2007)
CDS, Watson genome 4 (Wheeler, et al., 2008)
genes (CDS + introns) 5.4 (Cargill, et al., 1999)
genes (CDS + introns) 5.6 (Bhangale, et al., 2005)
introns, Venter genome 5.6 (Levy, et al., 2007)
introns, Watson genome 6.2 (Wheeler, et al., 2008)
Venter genome, total 6.2 (Levy, et al., 2007)
Watson genome, total 6.5 (Wheeler, et al., 2008)
genes (CDS + introns) 6.7 (Livingston, et al., 2004)
CDS 8 (Halushka, et al., 1999)
8q24 area 10.2 (Yeager, et al., 2008)
non RACEfrags(introns) 6.8 present study
RACEfrags 10.5 present study
The values from the present study are listed on the bottom. All of them are represented as 10−4. CDS : Coding Sequence
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